Global Biologics and Biosimilars Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
- HNY32077
- Slides: 131
- June 2021
- Total Views: 1154
- Region : Global
- HNY Research
- Market Research Report
About the Report
About the Report
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Roche
Eli Lilly
Sanofi-Aventis
Amgen
Novo Nordisk
AbbVie
Merck
Pfizer
Johnson & Johnson
Novartis
Gelgen
Ganlee
3sbio
Innovent
Biotech
Changchun High Tech
Dong Bao
CP Guojian
By Types:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
By Applications:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Products
Table of Contents
Table of Contents
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Biologics and Biosimilars Revenue
1.5 Market Analysis by Type
1.5.1 Global Biologics and Biosimilars Market Size Growth Rate by Type: 2021 VS 2027
1.5.2 Monoclonal Antibodies
1.5.3 Interferon
1.5.4 Erythropoietin
1.5.5 Insulin
1.5.6 Vaccines
1.5.7 Other
1.6 Market by Application
1.6.1 Global Biologics and Biosimilars Market Share by Application: 2022-2027
1.6.2 Tumor
1.6.3 Diabetes
1.6.4 Cardiovascular
1.6.5 Hemophilia
1.6.6 Other
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Biologics and Biosimilars Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter's Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Biologics and Biosimilars Market Players Profiles
3.1 Roche
3.1.1 Roche Company Profile
3.1.2 Roche Biologics and Biosimilars Product Specification
3.1.3 Roche Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.2 Eli Lilly
3.2.1 Eli Lilly Company Profile
3.2.2 Eli Lilly Biologics and Biosimilars Product Specification
3.2.3 Eli Lilly Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.3 Sanofi-Aventis
3.3.1 Sanofi-Aventis Company Profile
3.3.2 Sanofi-Aventis Biologics and Biosimilars Product Specification
3.3.3 Sanofi-Aventis Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 Amgen
3.4.1 Amgen Company Profile
3.4.2 Amgen Biologics and Biosimilars Product Specification
3.4.3 Amgen Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Novo Nordisk
3.5.1 Novo Nordisk Company Profile
3.5.2 Novo Nordisk Biologics and Biosimilars Product Specification
3.5.3 Novo Nordisk Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 AbbVie
3.6.1 AbbVie Company Profile
3.6.2 AbbVie Biologics and Biosimilars Product Specification
3.6.3 AbbVie Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Merck
3.7.1 Merck Company Profile
3.7.2 Merck Biologics and Biosimilars Product Specification
3.7.3 Merck Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Pfizer
3.8.1 Pfizer Company Profile
3.8.2 Pfizer Biologics and Biosimilars Product Specification
3.8.3 Pfizer Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Johnson & Johnson
3.9.1 Johnson & Johnson Company Profile
3.9.2 Johnson & Johnson Biologics and Biosimilars Product Specification
3.9.3 Johnson & Johnson Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Novartis
3.10.1 Novartis Company Profile
3.10.2 Novartis Biologics and Biosimilars Product Specification
3.10.3 Novartis Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 Gelgen
3.11.1 Gelgen Company Profile
3.11.2 Gelgen Biologics and Biosimilars Product Specification
3.11.3 Gelgen Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Ganlee
3.12.1 Ganlee Company Profile
3.12.2 Ganlee Biologics and Biosimilars Product Specification
3.12.3 Ganlee Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.13 3sbio
3.13.1 3sbio Company Profile
3.13.2 3sbio Biologics and Biosimilars Product Specification
3.13.3 3sbio Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.14 Innovent
3.14.1 Innovent Company Profile
3.14.2 Innovent Biologics and Biosimilars Product Specification
3.14.3 Innovent Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.15 Biotech
3.15.1 Biotech Company Profile
3.15.2 Biotech Biologics and Biosimilars Product Specification
3.15.3 Biotech Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.16 Changchun High Tech
3.16.1 Changchun High Tech Company Profile
3.16.2 Changchun High Tech Biologics and Biosimilars Product Specification
3.16.3 Changchun High Tech Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.17 Dong Bao
3.17.1 Dong Bao Company Profile
3.17.2 Dong Bao Biologics and Biosimilars Product Specification
3.17.3 Dong Bao Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.18 CP Guojian
3.18.1 CP Guojian Company Profile
3.18.2 CP Guojian Biologics and Biosimilars Product Specification
3.18.3 CP Guojian Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Biologics and Biosimilars Market Competition by Market Players
4.1 Global Biologics and Biosimilars Production Capacity Market Share by Market Players (2016-2021)
4.2 Global Biologics and Biosimilars Revenue Market Share by Market Players (2016-2021)
4.3 Global Biologics and Biosimilars Average Price by Market Players (2016-2021)
5 Global Biologics and Biosimilars Production by Regions (2016-2021)
5.1 North America
5.1.1 North America Biologics and Biosimilars Market Size (2016-2021)
5.1.2 Biologics and Biosimilars Key Players in North America (2016-2021)
5.1.3 North America Biologics and Biosimilars Market Size by Type (2016-2021)
5.1.4 North America Biologics and Biosimilars Market Size by Application (2016-2021)
5.2 East Asia
5.2.1 East Asia Biologics and Biosimilars Market Size (2016-2021)
5.2.2 Biologics and Biosimilars Key Players in East Asia (2016-2021)
5.2.3 East Asia Biologics and Biosimilars Market Size by Type (2016-2021)
5.2.4 East Asia Biologics and Biosimilars Market Size by Application (2016-2021)
5.3 Europe
5.3.1 Europe Biologics and Biosimilars Market Size (2016-2021)
5.3.2 Biologics and Biosimilars Key Players in Europe (2016-2021)
5.3.3 Europe Biologics and Biosimilars Market Size by Type (2016-2021)
5.3.4 Europe Biologics and Biosimilars Market Size by Application (2016-2021)
5.4 South Asia
5.4.1 South Asia Biologics and Biosimilars Market Size (2016-2021)
5.4.2 Biologics and Biosimilars Key Players in South Asia (2016-2021)
5.4.3 South Asia Biologics and Biosimilars Market Size by Type (2016-2021)
5.4.4 South Asia Biologics and Biosimilars Market Size by Application (2016-2021)
5.5 Southeast Asia
5.5.1 Southeast Asia Biologics and Biosimilars Market Size (2016-2021)
5.5.2 Biologics and Biosimilars Key Players in Southeast Asia (2016-2021)
5.5.3 Southeast Asia Biologics and Biosimilars Market Size by Type (2016-2021)
5.5.4 Southeast Asia Biologics and Biosimilars Market Size by Application (2016-2021)
5.6 Middle East
5.6.1 Middle East Biologics and Biosimilars Market Size (2016-2021)
5.6.2 Biologics and Biosimilars Key Players in Middle East (2016-2021)
5.6.3 Middle East Biologics and Biosimilars Market Size by Type (2016-2021)
5.6.4 Middle East Biologics and Biosimilars Market Size by Application (2016-2021)
5.7 Africa
5.7.1 Africa Biologics and Biosimilars Market Size (2016-2021)
5.7.2 Biologics and Biosimilars Key Players in Africa (2016-2021)
5.7.3 Africa Biologics and Biosimilars Market Size by Type (2016-2021)
5.7.4 Africa Biologics and Biosimilars Market Size by Application (2016-2021)
5.8 Oceania
5.8.1 Oceania Biologics and Biosimilars Market Size (2016-2021)
5.8.2 Biologics and Biosimilars Key Players in Oceania (2016-2021)
5.8.3 Oceania Biologics and Biosimilars Market Size by Type (2016-2021)
5.8.4 Oceania Biologics and Biosimilars Market Size by Application (2016-2021)
5.9 South America
5.9.1 South America Biologics and Biosimilars Market Size (2016-2021)
5.9.2 Biologics and Biosimilars Key Players in South America (2016-2021)
5.9.3 South America Biologics and Biosimilars Market Size by Type (2016-2021)
5.9.4 South America Biologics and Biosimilars Market Size by Application (2016-2021)
5.10 Rest of the World
5.10.1 Rest of the World Biologics and Biosimilars Market Size (2016-2021)
5.10.2 Biologics and Biosimilars Key Players in Rest of the World (2016-2021)
5.10.3 Rest of the World Biologics and Biosimilars Market Size by Type (2016-2021)
5.10.4 Rest of the World Biologics and Biosimilars Market Size by Application (2016-2021)
6 Global Biologics and Biosimilars Consumption by Region (2016-2021)
6.1 North America
6.1.1 North America Biologics and Biosimilars Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Biologics and Biosimilars Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Biologics and Biosimilars Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Biologics and Biosimilars Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Biologics and Biosimilars Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Biologics and Biosimilars Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Biologics and Biosimilars Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Biologics and Biosimilars Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Biologics and Biosimilars Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Biologics and Biosimilars Consumption by Countries
7 Global Biologics and Biosimilars Production Forecast by Regions (2022-2027)
7.1 Global Forecasted Production of Biologics and Biosimilars (2022-2027)
7.2 Global Forecasted Revenue of Biologics and Biosimilars (2022-2027)
7.3 Global Forecasted Price of Biologics and Biosimilars (2022-2027)
7.4 Global Forecasted Production of Biologics and Biosimilars by Region (2022-2027)
7.4.1 North America Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.2 East Asia Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.3 Europe Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.4 South Asia Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.5 Southeast Asia Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.6 Middle East Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.7 Africa Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.8 Oceania Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.9 South America Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.4.10 Rest of the World Biologics and Biosimilars Production, Revenue Forecast (2022-2027)
7.5 Forecast by Type and by Application (2022-2027)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
7.5.2 Global Forecasted Consumption of Biologics and Biosimilars by Application (2022-2027)
8 Global Biologics and Biosimilars Consumption Forecast by Regions (2022-2027)
8.1 North America Forecasted Consumption of Biologics and Biosimilars by Country
8.2 East Asia Market Forecasted Consumption of Biologics and Biosimilars by Country
8.3 Europe Market Forecasted Consumption of Biologics and Biosimilars by Countriy
8.4 South Asia Forecasted Consumption of Biologics and Biosimilars by Country
8.5 Southeast Asia Forecasted Consumption of Biologics and Biosimilars by Country
8.6 Middle East Forecasted Consumption of Biologics and Biosimilars by Country
8.7 Africa Forecasted Consumption of Biologics and Biosimilars by Country
8.8 Oceania Forecasted Consumption of Biologics and Biosimilars by Country
8.9 South America Forecasted Consumption of Biologics and Biosimilars by Country
8.10 Rest of the world Forecasted Consumption of Biologics and Biosimilars by Country
9 Global Biologics and Biosimilars Sales by Type (2016-2027)
9.1 Global Biologics and Biosimilars Historic Market Size by Type (2016-2021)
9.2 Global Biologics and Biosimilars Forecasted Market Size by Type (2022-2027)
10 Global Biologics and Biosimilars Consumption by Application (2016-2027)
10.1 Global Biologics and Biosimilars Historic Market Size by Application (2016-2021)
10.2 Global Biologics and Biosimilars Forecasted Market Size by Application (2022-2027)
11 Global Biologics and Biosimilars Manufacturing Cost Analysis
11.1 Biologics and Biosimilars Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Biologics and Biosimilars
12 Global Biologics and Biosimilars Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Biologics and Biosimilars Distributors List
12.3 Biologics and Biosimilars Customers
12.4 Biologics and Biosimilars Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer
List of Figure
Figure 1. Product Figure
Figure 2. Global Biologics and Biosimilars Market Share by Type: 2021 VS 2027
Figure 3. Global Biologics and Biosimilars Market Share by Application: 2021 VS 2027
Figure 4. North America Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Figure 5. North America Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 6. North America Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 7. United States Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 8. Canada Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 9. Mexico Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 10. East Asia Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 11. East Asia Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 12. China Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 13. Japan Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 14. South Korea Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 15. Europe Biologics and Biosimilars Consumption and Growth Rate
Figure 16. Europe Biologics and Biosimilars Consumption Market Share by Region in 2021
Figure 17. Germany Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 18. United Kingdom Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 19. France Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 20. Italy Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 21. Russia Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 22. Spain Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 23. Netherlands Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 24. Switzerland Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 25. Poland Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 26. South Asia Biologics and Biosimilars Consumption and Growth Rate
Figure 27. South Asia Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 28. India Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 29. Southeast Asia Biologics and Biosimilars Consumption and Growth Rate
Figure 30. Southeast Asia Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 31. Indonesia Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 32. Thailand Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 33. Singapore Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 34. Malaysia Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 35. Philippines Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 36. Middle East Biologics and Biosimilars Consumption and Growth Rate
Figure 37. Middle East Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 38. Turkey Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 39. Saudi Arabia Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 40. Iran Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 41. United Arab Emirates Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 42. Africa Biologics and Biosimilars Consumption and Growth Rate
Figure 43. Africa Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 44. Nigeria Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 45. South Africa Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 46. Oceania Biologics and Biosimilars Consumption and Growth Rate
Figure 47. Oceania Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 48. Australia Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 49. South America Biologics and Biosimilars Consumption and Growth Rate
Figure 50. South America Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 51. Brazil Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 52. Argentina Biologics and Biosimilars Consumption and Growth Rate (2016-2021)
Figure 53. Rest of the World Biologics and Biosimilars Consumption and Growth Rate
Figure 54. Rest of the World Biologics and Biosimilars Consumption Market Share by Countries in 2021
Figure 55. Global Biologics and Biosimilars Production Capacity Growth Rate Forecast (2022-2027)
Figure 56. Global Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 57. Global Biologics and Biosimilars Price and Trend Forecast (2022-2027)
Figure 58. North America Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 59. North America Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 60. East Asia Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 61. East Asia Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 62. Europe Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 63. Europe Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 64. South Asia Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 65. South Asia Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 66. Southeast Asia Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 67. Southeast Asia Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 68. Middle East Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 69. Middle East Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 70. Africa Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 71. Africa Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 72. Oceania Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 73. Oceania Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 74. South America Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 75. South America Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 76. Rest of the World Biologics and Biosimilars Production Growth Rate Forecast (2022-2027)
Figure 77. Rest of the World Biologics and Biosimilars Revenue Growth Rate Forecast (2022-2027)
Figure 78. North America Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 79. East Asia Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 80. Europe Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 81. South Asia Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 82. Southeast Asia Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 83. Middle East Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 84. Africa Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 85. Oceania Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 86. South America Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 87. Rest of the world Biologics and Biosimilars Consumption Forecast 2022-2027
Figure 88. Manufacturing Cost Structure of Biologics and Biosimilars
Figure 89. Manufacturing Process Analysis of Biologics and Biosimilars
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Biologics and Biosimilars Supply Chain Analysis
List of Table
Table 1. Research Programs/Design for This Report
Table 2. Key Data Information from Secondary Sources
Table 3. Key Executives Interviewed
Table 4. Key Data Information from Primary Sources
Table 5. Key Players Covered: Ranking by Biologics and Biosimilars Revenue (USD Million) 2016-2021
Table 6. Global Biologics and Biosimilars Market Size by Type (USD Million): 2022-2027
Table 7. Monoclonal Antibodies Features
Table 8. Interferon Features
Table 9. Erythropoietin Features
Table 10. Insulin Features
Table 11. Vaccines Features
Table 12. Other Features
Table 16. Global Biologics and Biosimilars Market Size by Application (USD Million): 2022-2027
Table 17. Tumor Case Studies
Table 18. Diabetes Case Studies
Table 19. Cardiovascular Case Studies
Table 20. Hemophilia Case Studies
Table 21. Other Case Studies
Table 26. Overview of the World Economic Outlook Projections
Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 32. Commodity Prices-Metals Price Indices
Table 33. Commodity Prices- Precious Metal Price Indices
Table 34. Commodity Prices- Agricultural Raw Material Price Indices
Table 35. Commodity Prices- Food and Beverage Price Indices
Table 36. Commodity Prices- Fertilizer Price Indices
Table 37. Commodity Prices- Energy Price Indices
Table 38. G20+: Economic Policy Responses to COVID-19
Table 39. Covid-19 Impact: Global Major Government Policy
Table 40. Biologics and Biosimilars Report Years Considered
Table 41. Market Top Trends
Table 42. Key Drivers: Impact Analysis
Table 43. Key Challenges
Table 44. Porter's Five Forces Analysis
Table 45. Biologics and Biosimilars Market Growth Strategy
Table 46. Biologics and Biosimilars SWOT Analysis
Table 47. Roche Biologics and Biosimilars Product Specification
Table 48. Roche Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 49. Eli Lilly Biologics and Biosimilars Product Specification
Table 50. Eli Lilly Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 51. Sanofi-Aventis Biologics and Biosimilars Product Specification
Table 52. Sanofi-Aventis Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 53. Amgen Biologics and Biosimilars Product Specification
Table 54. Table Amgen Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 55. Novo Nordisk Biologics and Biosimilars Product Specification
Table 56. Novo Nordisk Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 57. AbbVie Biologics and Biosimilars Product Specification
Table 58. AbbVie Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 59. Merck Biologics and Biosimilars Product Specification
Table 60. Merck Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 61. Pfizer Biologics and Biosimilars Product Specification
Table 62. Pfizer Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 63. Johnson & Johnson Biologics and Biosimilars Product Specification
Table 64. Johnson & Johnson Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 65. Novartis Biologics and Biosimilars Product Specification
Table 66. Novartis Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 67. Gelgen Biologics and Biosimilars Product Specification
Table 68. Gelgen Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 69. Ganlee Biologics and Biosimilars Product Specification
Table 70. Ganlee Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 71. 3sbio Biologics and Biosimilars Product Specification
Table 72. 3sbio Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 73. Innovent Biologics and Biosimilars Product Specification
Table 74. Innovent Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 75. Biotech Biologics and Biosimilars Product Specification
Table 76. Biotech Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 77. Changchun High Tech Biologics and Biosimilars Product Specification
Table 78. Changchun High Tech Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 79. Dong Bao Biologics and Biosimilars Product Specification
Table 80. Dong Bao Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 81. CP Guojian Biologics and Biosimilars Product Specification
Table 82. CP Guojian Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table 147. Global Biologics and Biosimilars Production Capacity by Market Players
Table 148. Global Biologics and Biosimilars Production by Market Players (2016-2021)
Table 149. Global Biologics and Biosimilars Production Market Share by Market Players (2016-2021)
Table 150. Global Biologics and Biosimilars Revenue by Market Players (2016-2021)
Table 151. Global Biologics and Biosimilars Revenue Share by Market Players (2016-2021)
Table 152. Global Market Biologics and Biosimilars Average Price of Key Market Players (2016-2021)
Table 153. North America Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 154. North America Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 155. North America Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 156. North America Biologics and Biosimilars Market Share by Type (2016-2021)
Table 157. North America Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 158. North America Biologics and Biosimilars Market Share by Application (2016-2021)
Table 159. East Asia Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 160. East Asia Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 161. East Asia Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 162. East Asia Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 163. East Asia Biologics and Biosimilars Market Share by Type (2016-2021)
Table 164. East Asia Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 165. East Asia Biologics and Biosimilars Market Share by Application (2016-2021)
Table 166. Europe Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 167. Europe Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 168. Europe Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 169. Europe Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 170. Europe Biologics and Biosimilars Market Share by Type (2016-2021)
Table 171. Europe Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 172. Europe Biologics and Biosimilars Market Share by Application (2016-2021)
Table 173. South Asia Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 174. South Asia Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 175. South Asia Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 176. South Asia Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 177. South Asia Biologics and Biosimilars Market Share by Type (2016-2021)
Table 178. South Asia Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 179. South Asia Biologics and Biosimilars Market Share by Application (2016-2021)
Table 180. Southeast Asia Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 181. Southeast Asia Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 182. Southeast Asia Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 183. Southeast Asia Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 184. Southeast Asia Biologics and Biosimilars Market Share by Type (2016-2021)
Table 185. Southeast Asia Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 186. Southeast Asia Biologics and Biosimilars Market Share by Application (2016-2021)
Table 187. Middle East Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 188. Middle East Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 189. Middle East Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 190. Middle East Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 191. Middle East Biologics and Biosimilars Market Share by Type (2016-2021)
Table 192. Middle East Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 193. Middle East Biologics and Biosimilars Market Share by Application (2016-2021)
Table 194. Africa Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 195. Africa Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 196. Africa Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 197. Africa Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 198. Africa Biologics and Biosimilars Market Share by Type (2016-2021)
Table 199. Africa Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 200. Africa Biologics and Biosimilars Market Share by Application (2016-2021)
Table 201. Oceania Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 202. Oceania Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 203. Oceania Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 204. Oceania Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 205. Oceania Biologics and Biosimilars Market Share by Type (2016-2021)
Table 206. Oceania Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 207. Oceania Biologics and Biosimilars Market Share by Application (2016-2021)
Table 208. South America Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 209. South America Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 210. South America Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 211. South America Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 212. South America Biologics and Biosimilars Market Share by Type (2016-2021)
Table 213. South America Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 214. South America Biologics and Biosimilars Market Share by Application (2016-2021)
Table 215. Rest of the World Biologics and Biosimilars Market Size YoY Growth (2016-2021) (USD Million)
Table 216. Rest of the World Key Players Biologics and Biosimilars Revenue (2016-2021) (USD Million)
Table 217. Rest of the World Key Players Biologics and Biosimilars Market Share (2016-2021)
Table 218. Rest of the World Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 219. Rest of the World Biologics and Biosimilars Market Share by Type (2016-2021)
Table 220. Rest of the World Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 221. Rest of the World Biologics and Biosimilars Market Share by Application (2016-2021)
Table 222. North America Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 223. East Asia Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 224. Europe Biologics and Biosimilars Consumption by Region (2016-2021)
Table 225. South Asia Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 226. Southeast Asia Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 227. Middle East Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 228. Africa Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 229. Oceania Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 230. South America Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 231. Rest of the World Biologics and Biosimilars Consumption by Countries (2016-2021)
Table 232. Global Biologics and Biosimilars Production Forecast by Region (2022-2027)
Table 233. Global Biologics and Biosimilars Sales Volume Forecast by Type (2022-2027)
Table 234. Global Biologics and Biosimilars Sales Volume Market Share Forecast by Type (2022-2027)
Table 235. Global Biologics and Biosimilars Sales Revenue Forecast by Type (2022-2027)
Table 236. Global Biologics and Biosimilars Sales Revenue Market Share Forecast by Type (2022-2027)
Table 237. Global Biologics and Biosimilars Sales Price Forecast by Type (2022-2027)
Table 238. Global Biologics and Biosimilars Consumption Volume Forecast by Application (2022-2027)
Table 239. Global Biologics and Biosimilars Consumption Value Forecast by Application (2022-2027)
Table 240. North America Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 241. East Asia Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 242. Europe Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 243. South Asia Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 244. Southeast Asia Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 245. Middle East Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 246. Africa Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 247. Oceania Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 248. South America Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 249. Rest of the world Biologics and Biosimilars Consumption Forecast 2022-2027 by Country
Table 250. Global Biologics and Biosimilars Market Size by Type (2016-2021) (USD Million)
Table 251. Global Biologics and Biosimilars Revenue Market Share by Type (2016-2021)
Table 252. Global Biologics and Biosimilars Forecasted Market Size by Type (2022-2027) (USD Million)
Table 253. Global Biologics and Biosimilars Revenue Market Share by Type (2022-2027)
Table 254. Global Biologics and Biosimilars Market Size by Application (2016-2021) (USD Million)
Table 255. Global Biologics and Biosimilars Revenue Market Share by Application (2016-2021)
Table 256. Global Biologics and Biosimilars Forecasted Market Size by Application (2022-2027) (USD Million)
Table 257. Global Biologics and Biosimilars Revenue Market Share by Application (2022-2027)
Table 258. Biologics and Biosimilars Distributors List
Table 259. Biologics and Biosimilars Customers List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.